M

Medinno

3 employees

Medinno develops cell therapeutics for brain diseases.

Basic info

Industry

biotechnology research

Sectors

Brain tumor
Mesenchymal stem cell
Hypoxic ischemic encephalopathy
Stroke
Health Care
Therapeutics
Neural stem cell
Intraventricular hemorrhage
Cell Therapy
Spinal cord injury
Gene therapy

Date founded

2018

Funding rounds raised

M

Medinno raised undisclosed on January 1, 2019

Investors: Company K Partners

FAQ